Barclays »

Cocrystal Pharma shares owned by Barclays

Quarter-by-quarter ownership of Cocrystal Pharma (COCP) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Cocrystal Pharma

Tip: Access up to 7 years of quarterly data

All positions including Cocrystal Pharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cocrystal Pharma by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $20 16 1.25

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Cocrystal Pharma

Vanguard Group
Renaissance Technologies
Geode Capital Management
BlackRock
Neuberger Berman Group
Jane Street
State Street Corporation
Parallel Advisors
Northern Trust
Morgan Stanley
Tower Research Capital
Wells Fargo & Company
Northwestern Mutual Wealth Management Company
UBS Group
Clean Yield Group

View all funds holding Cocrystal Pharma